IT1238231B - Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori - Google Patents

Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori

Info

Publication number
IT1238231B
IT1238231B IT02272589A IT2272589A IT1238231B IT 1238231 B IT1238231 B IT 1238231B IT 02272589 A IT02272589 A IT 02272589A IT 2272589 A IT2272589 A IT 2272589A IT 1238231 B IT1238231 B IT 1238231B
Authority
IT
Italy
Prior art keywords
immunomodulants
chemotherapy
cancer therapy
synergic agents
synergic
Prior art date
Application number
IT02272589A
Other languages
English (en)
Other versions
IT8922725A1 (it
IT8922725A0 (it
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Priority to IT02272589A priority Critical patent/IT1238231B/it
Publication of IT8922725A0 publication Critical patent/IT8922725A0/it
Priority to EP90123297A priority patent/EP0433765A1/en
Priority to JP2411343A priority patent/JPH049338A/ja
Publication of IT8922725A1 publication Critical patent/IT8922725A1/it
Application granted granted Critical
Publication of IT1238231B publication Critical patent/IT1238231B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/32—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT02272589A 1989-12-18 1989-12-18 Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori IT1238231B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT02272589A IT1238231B (it) 1989-12-18 1989-12-18 Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori
EP90123297A EP0433765A1 (en) 1989-12-18 1990-12-05 The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy
JP2411343A JPH049338A (ja) 1989-12-18 1990-12-18 腫瘍治療における化学療法薬の共働剤としての免疫調整剤の使用方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02272589A IT1238231B (it) 1989-12-18 1989-12-18 Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori

Publications (3)

Publication Number Publication Date
IT8922725A0 IT8922725A0 (it) 1989-12-18
IT8922725A1 IT8922725A1 (it) 1991-06-18
IT1238231B true IT1238231B (it) 1993-07-12

Family

ID=11199710

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02272589A IT1238231B (it) 1989-12-18 1989-12-18 Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori

Country Status (3)

Country Link
EP (1) EP0433765A1 (it)
JP (1) JPH049338A (it)
IT (1) IT1238231B (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410010B1 (en) 1992-10-13 2002-06-25 Board Of Regents, The University Of Texas System Recombinant P53 adenovirus compositions
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
AU663702B2 (en) 1991-03-06 1995-10-19 Board Of Regents, The University Of Texas System Methods and compositions for the selective inhibition of gene expression
CN1094310A (zh) * 1992-12-15 1994-11-02 托马斯·C·梅里根 人体免疫缺陷性病毒感染用组合式化学疗法
US5632983A (en) * 1994-11-17 1997-05-27 University Of South Florida Method for treating secondary immunodeficiency
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
WO1998022588A2 (en) 1996-11-20 1998-05-28 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US6084687A (en) * 1996-12-25 2000-07-04 Fuji Xerox Co., Ltd. Image processing system, drawing system, drawing method, medium, printer, and image display unit
US6787132B1 (en) 1997-12-04 2004-09-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Combined chemo-immunotherapy with liposomal drugs and cytokines
IL136343A0 (en) * 1997-12-04 2001-05-20 Yissum Res Dev Co Combined chemo-immunotherapy with liposomal drugs and cytokines
US6689600B1 (en) 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
CA2464228C (en) 2000-10-27 2017-01-17 Immuno-Rx, Inc. Vaccine immunotherapy for immune suppressed patients
UA77999C2 (en) * 2001-12-10 2007-02-15 Thymosin-alpha 1 for treatment of malignant glioblastoma
CA2586107A1 (en) 2004-11-03 2006-05-18 Introgen Therapeutics Inc. A novel method for the production and purification of adenoviral vectors
EP2205268B1 (en) 2007-06-15 2012-08-15 HI-STEM Heidelberg Institute for Stem Cell Technology and Experimental Medicine gemeinnützige GmbH Interferon alpha sequential regimen for treating cancers
JP2010538985A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 抗ｈｉｖ剤としての副甲状腺ホルモン（１−３４）の使用
AU2008310007A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Combination of splenopentin and thymopentin and the use thereof in medicine
WO2009040023A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of galnon as a therapeutic agent
US7993660B2 (en) 2007-11-28 2011-08-09 Irx Therapeutics, Inc. Method of increasing immunological effect
JP5797190B2 (ja) 2009-05-15 2015-10-21 アイ アール エックス セーラピューティクス， インコーポレイテッド ワクチン免疫療法
US9333238B2 (en) 2009-12-08 2016-05-10 Irx Therapeutics, Inc. Method of immunotherapy for treament of human papillomavirus infection
JP6948685B2 (ja) * 2016-11-04 2021-10-13 国立大学法人金沢大学 抗癌作用増強剤及び癌治療支援方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978332A (en) * 1987-09-28 1990-12-18 Matrix Pharmaceutical, Inc. Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids

Also Published As

Publication number Publication date
IT8922725A1 (it) 1991-06-18
IT8922725A0 (it) 1989-12-18
JPH049338A (ja) 1992-01-14
EP0433765A1 (en) 1991-06-26

Similar Documents

Publication Publication Date Title
IT8922725A0 (it) Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori
FI904257A7 (fi) Syövän hoidossa käytettäviä uusia tuotteita
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
EP0888458A4 (en) COMBINATION OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCER
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
FI955906A7 (fi) O6-substituoituja guaniinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö kasvainsolujen hoidossa
AU581853B2 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
ITRM910730A0 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" diradicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali
FI945694L (fi) Substituoiden triatsolin sulfaattisuola, sen farmaseuttisia koostumuksia ja niiden käyttö terapiassa
IT1123142B (it) Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
IT8620690A1 (it) Alchil o aralchil tio-2 cicloalchene-1 carbossammidi-1 e loro solfossidi, procedimenti per la loro preparazione e loro applicazione nella sintesi di tri e tetrametilen-4,5 isotiazolin-4 oni-3'
IL101317A0 (en) New compounds for use in the treatment of cancer
FI961339A7 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
IT1232584B (it) Miglioramenti nella struttura di cassetti per mobili
GB9219776D0 (en) New compounds for use in the treatment of cancer
FI96742C (fi) Minoksidiilia sisältävä 1-faasigeelikoostumus ja menetelmä sen valmistamiseksi
IT1188704B (it) Derivati insaturi cicloalifatici,loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica
IT8109468A0 (it) Uso di derivati mercaptoacilsostituiti della prolina nella terapia delle cefalee essenziali
ITMI911122A0 (it) Composizioni per la terapia topica delle ustioni
KR930703331A (ko) 비사이클로폴리아자매크로사이클로카복실산 착체, 그의 결합체, 그의 제조방법 및 방사성 약제로서의 그의 용도
IT1276321B1 (it) Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono
IT8322370A0 (it) Applicazione terapeutica delmazindolo nella malattia di parkinson.
IT1190782B (it) Derivati diossazabiciclici,loro procedimento di preparazione e loro applicazione in terapia
IT9022513A0 (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19951229